This inventor holds 1 USPTO granted patent. Top assignee: Summit Corporation Plc. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Neil Robinson: Innovator in Pharmaceutical Composition for Duchenne Muscular Dystrophy
Introduction
Neil Robinson is a notable inventor based in Aylesbury, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Duchenne muscular dystrophy. His innovative work has the potential to improve the lives of many individuals affected by this condition.
Latest Patents
Neil Robinson holds a patent for a pharmaceutical composition aimed at treating Duchenne muscular dystrophy. This invention relates to pharmaceutical compositions comprising 5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole (C1100). The patent details processes for preparing these compositions and outlines various therapeutic uses of the combinations. Additionally, it provides a method for treating Duchenne muscular dystrophy or Becker muscular dystrophy using these compositions. He has 1 patent to his name.
Career Highlights
Neil Robinson is associated with Summit Corporation Plc, where he has been instrumental in advancing pharmaceutical research and development. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Neil collaborates with Jonathon Mark Tinsley, working together to enhance the effectiveness of their research and development efforts.
Conclusion
Neil Robinson's contributions to pharmaceutical compositions for treating Duchenne muscular dystrophy highlight his commitment to innovation in healthcare. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile